全文获取类型
收费全文 | 6714篇 |
免费 | 476篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 139篇 |
妇产科学 | 129篇 |
基础医学 | 909篇 |
口腔科学 | 150篇 |
临床医学 | 589篇 |
内科学 | 1577篇 |
皮肤病学 | 127篇 |
神经病学 | 454篇 |
特种医学 | 186篇 |
外国民族医学 | 1篇 |
外科学 | 919篇 |
综合类 | 141篇 |
一般理论 | 3篇 |
预防医学 | 564篇 |
眼科学 | 303篇 |
药学 | 524篇 |
中国医学 | 77篇 |
肿瘤学 | 394篇 |
出版年
2024年 | 13篇 |
2023年 | 106篇 |
2022年 | 243篇 |
2021年 | 369篇 |
2020年 | 260篇 |
2019年 | 328篇 |
2018年 | 376篇 |
2017年 | 268篇 |
2016年 | 300篇 |
2015年 | 291篇 |
2014年 | 372篇 |
2013年 | 445篇 |
2012年 | 675篇 |
2011年 | 628篇 |
2010年 | 367篇 |
2009年 | 306篇 |
2008年 | 389篇 |
2007年 | 372篇 |
2006年 | 293篇 |
2005年 | 191篇 |
2004年 | 170篇 |
2003年 | 149篇 |
2002年 | 106篇 |
2001年 | 17篇 |
2000年 | 21篇 |
1999年 | 20篇 |
1998年 | 18篇 |
1997年 | 11篇 |
1996年 | 17篇 |
1995年 | 10篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 5篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 7篇 |
1988年 | 4篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1971年 | 6篇 |
排序方式: 共有7254条查询结果,搜索用时 15 毫秒
71.
Khalil Ghasemi Falavarjani Joobin Khadamy Arezoo Karimi Moghaddam Nasser Karimi Mehdi Modarres 《Saudi Journal of Ophthalmology》2015,29(4):270-273
Purpose
To evaluate the short-term results of sub-tenon’s injection of bevacizumab in patients with clinically significant macular edema (CSME).Methods
In this prospective non-comparative interventional case series, sub-tenon’s injection of 2.5 mg/0.1 ml bevacizumab was performed for eyes with CSME. Macular thickness and best corrected visual acuity measurements were performed before and one month after injections.Results
Nineteen eyes of twelve patients with a mean age of 59.8 ± 5.7 years were evaluated. Thirteen eyes (68.4%) had center-involving macular edema. No significant difference was observed between pre- and post-injection central subfield retinal thickness measurements (P = 0.3). Central subfield thickness measurements improved or remained unchanged in 13 eyes (68.4%). Baseline BCVA of 0.48 ± 0.35 LogMAR improved to 0.36 ± 0.26 LogMAR after injection (P = 0.01). Improvement of >2 lines in BCVA was found in 5 eyes (26.3%), and no eye lost >2 lines of BCVA. No complication associated with sub-tenon’s injection was observed.Conclusion
Sub-tenon’s injection of bevacizumab resulted in significant short-term visual improvement in eyes with CSME. Retinal thickness changes were not significant. 相似文献72.
Esalatmanesh Kamal Loghman Amirhossein Esalatmanesh Roozbeh Soleimani Zahra Khabbazi Alireza Mahdavi Aida Malek Mousavi Seyed Gholam Abbas 《Clinical rheumatology》2021,40(9):3591-3597
Clinical Rheumatology - Considering the pathologic significance of inflammation and oxidative stress in rheumatoid arthritis (RA) as well as the antioxidant, anti-inflammatory and hypolipidemic... 相似文献
73.
Razavi Yasaman Keyhanfar Fariborz Haghparast Abbas Shabani Ronak Mehdizadeh Mehdi 《Metabolic brain disease》2021,36(6):1381-1390
Metabolic Brain Disease - Chronic methamphetamine (meth) abuse can lead to certain deficits in the hippocampal function by affecting the hippocampal neurogenesis and plasticity. To determine... 相似文献
74.
Sport Sciences for Health - Extrinsic and intrinsic foot muscles actively support the foot’s arches, particularly the medial longitudinal arch. Previous studies have focused on strengthening... 相似文献
75.
Brkić Hrvoje Galić Ivan Vodanović Marin Dumančić Jelena Mehdi Fuad Anić Milošević Sandra 《International journal of legal medicine》2022,136(6):1685-1696
International Journal of Legal Medicine - This study aimed to evaluate the accuracy and precision of the Cameriere European formula, Demirjian, Haavikko, and Willems methods for estimating dental... 相似文献
76.
Kihara Eunice Galic Ivan Nyamunga Donna Mehdi Fuad Velandia Palacio Luz Andrea Cameriere Roberto 《International journal of legal medicine》2022,136(5):1495-1506
International Journal of Legal Medicine - This study aimed to validate the accuracy of five different formulas based on the Cameriere method for age estimation in Kenyan children. We analyzed... 相似文献
77.
Seyed Morteza Shamshirgaran Louisa Jorm Sanja Lujic Hilary Bambrick 《Primary Care Diabetes》2019,13(1):71-81
Background
Ethnic variation in the occurrence of type 2 diabetes, complications, mortality, and health behaviours has been reported. The current research examined patterns of health-related outcomes by country of birth in people with diabetes aged 45 years and over in New South Wales, Australia.Methods
This study was based on the baseline data of 266,848 participants aged 45 years and over from “The Sax Institute’s 45 and Up Study” (2006–2009), NSW; Australia’s most populous state. Health-related factors including self-rated overall health, Quality of Life (QoL), eyesight, subjective memory complaint, hearing loss, psychological distress and functional limitation were examined according to country of birth among 23,112 people with type 2 diabetes. Logistic regression modelling was used to compare the odds of poor outcomes between Australian-born and overseas-born participants, adjusting for potential confounding and mediating variables. Both age-sex and fully adjusted odds ratios (aORs) are reported.Results
Nearly half of the people with diabetes in the sample reported hearing loss and high levels of functional limitations, a third reported poor overall health. Compared to people with diabetes born in Australia, people born in South East Europe, North Africa, the Middle East had significantly greater odds of poor outcomes across the majority of examined health-related factors, with the largest odds observed in the elevated level of psychological distress outcome (aOR = 3.4 in North African and the Middle East group). Higher aORs of poor overall health, QoL, memory problems and poor eyesight, and lower aORs for hearing loss, were also found among those born in the Asian countries.Conclusions
The results demonstrated significant ethnic disparity in the prevalence of health-related outcomes. These findings provide important context for the formulation of culturally sensitive secondary prevention strategies. 相似文献78.
79.
Eosinophils are major effectors cells implicated in a number of chronic inflammatory diseases in humans, particularly bronchial asthma and allergic rhinitis. The human chemokine receptor C-C receptor 3 (hCCR3) provides a mechanism for the recruitment of eosinophils into tissue and thus has recently become an attractive biological target for therapeutic intervention. In order to develop peptides antagonists of hCCR3-hCCL11 (human eotaxin) interactions, a random bacteriophage hexapeptide library was used to map structural features of hCCR3 by determining the epitopes of neutralizing anti-hCCR3 mAb 7B11. This mAb t is selective for hCCR3 and exhibit potent antagonist activity in receptor binding and functional assays. After three rounds of biopanning, four mAb7B11-binding peptides were identified from a 6-mer linear peptide library. The phage bearing the peptides showed specific binding to immobilized mAb 7B11 with over 94% of phages bound being competitively inhibited by free synthetic peptides. In FACScan analysis all selected phage peptides were able to strongly inhibit the binding of mAb 7B11 to hCCR3-transfected preB-300-19 murine cells. Furthermore, synthetic peptides of the corresponding phage epitopes were effective in blocking the antibody–hCCR3 interactions and to inhibit the binding of hCCL11 to hCCR3 transfectants. Chemically synthesized peptides CKGERF, FERKGK, SSMKVK and RHVSSQ, effectively competed for 125I-hCCL11 binding to hCCR3 with IC50 ranging from 3.5 to 9.7 μM. Calcium release and chemotaxis of hCCR3 transfectants or human eosinophils were inhibited by all peptides in a dose-dependent manner. Furthermore, they showed inhibitory effects on chemotaxis of human eosinophils induced by hCCL11, hCCL5, hCCL7, hCCL8, and hCCL24. Specificities of all selected peptides were assessed with hCXCR1, hCXCR2, hCXCR3, and hCCR5 receptors. Peptides CKGERF and FERKGK showed inhibitory effects on eosinophil chemotaxis in a murine model of mCCL11-induced peritoneal eosinophilia. The development of peptides inhibiting the interactions between hCCR3 and its chemokine ligands will facilitate the development of small peptides antagonists with the hope of ameliorating chronic inflammatory diseases in humans. 相似文献
80.
Xu Zheyu Anderson Kirstie N. Saffari Seyed Ehsan Lawson Rachael A. Chaudhuri K. Ray Brooks David Pavese Nicola 《Journal of neurology》2021,268(1):312-320
Journal of Neurology - Sleep disorders can occur in early Parkinson’s disease (PD). However, the relationship between different sleep disturbances and their longitudinal evolution has not... 相似文献